We are proud to present a complete upgrade of the Cogmed product and platform, with a planned release date of November 3.
This is the starting point toward building a new future for a method that delivers substantial improvements in people's lives.
Cogmed is designed by cognitive neuroscientists and psychologists from the Karolinska Institute. Leading independent research teams worldwide have proven its efficacy in 100+ studies in peer-reviewed journals. The benefits are substantial and long-term regardless of age and condition.
Software alone is not sufficient to achieve cognitive enhancement. Cogmed distinguishes itself not only by being research-based, but also by delivering a complete solution guided by a coach to ensure motivation and compliance.Read more
Cogmed has an outstanding record for almost 20 years of strong and sustainable results in clinical settings.
Professionals in practices worldwide have achieved significant improvements for people with attention deficits (ADHD), learning difficulties, brain injuries and pediatric cancer survivors.
Ph.D. specialized in treatment of ADHD
M.D. specialised in developmental problems